Cargando…

Application of systemic treatment in conversion therapy options for liver cancer

Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bei, Haoyang, Mai, Weiheng, Chen, Weifeng, Li, Mingyi, Yang, Yongguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583895/
https://www.ncbi.nlm.nih.gov/pubmed/36276063
http://dx.doi.org/10.3389/fonc.2022.966821
_version_ 1784813168723230720
author Bei, Haoyang
Mai, Weiheng
Chen, Weifeng
Li, Mingyi
Yang, Yongguang
author_facet Bei, Haoyang
Mai, Weiheng
Chen, Weifeng
Li, Mingyi
Yang, Yongguang
author_sort Bei, Haoyang
collection PubMed
description Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc.
format Online
Article
Text
id pubmed-9583895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95838952022-10-21 Application of systemic treatment in conversion therapy options for liver cancer Bei, Haoyang Mai, Weiheng Chen, Weifeng Li, Mingyi Yang, Yongguang Front Oncol Oncology Radical hepatectomy is the main treatment method to improve the prognosis of patients with intermediate and early-stage liver cancer. Most liver cancer patients in China are in the advanced stage at the initial diagnosis, losing the opportunity for surgical treatment. Therefore, it is essential to down-stage unresectable liver cancer to resectable liver cancer clinically, which is an important way to improve patients’ survival and a hotspot of current clinical research. In recent years, with the increase in effective treatment methods for liver cancer, the resection rate of conversion surgery for unresectable advanced liver cancer has been significantly improved, and a growing number of patients benefit from conversion therapy. This article mainly reviews the connotation of conversion therapy for liver cancer, the patient selection, the selection of conversion strategy, the timing of sequential operations, the scheme and safety, etc. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9583895/ /pubmed/36276063 http://dx.doi.org/10.3389/fonc.2022.966821 Text en Copyright © 2022 Bei, Mai, Chen, Li and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Bei, Haoyang
Mai, Weiheng
Chen, Weifeng
Li, Mingyi
Yang, Yongguang
Application of systemic treatment in conversion therapy options for liver cancer
title Application of systemic treatment in conversion therapy options for liver cancer
title_full Application of systemic treatment in conversion therapy options for liver cancer
title_fullStr Application of systemic treatment in conversion therapy options for liver cancer
title_full_unstemmed Application of systemic treatment in conversion therapy options for liver cancer
title_short Application of systemic treatment in conversion therapy options for liver cancer
title_sort application of systemic treatment in conversion therapy options for liver cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583895/
https://www.ncbi.nlm.nih.gov/pubmed/36276063
http://dx.doi.org/10.3389/fonc.2022.966821
work_keys_str_mv AT beihaoyang applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer
AT maiweiheng applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer
AT chenweifeng applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer
AT limingyi applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer
AT yangyongguang applicationofsystemictreatmentinconversiontherapyoptionsforlivercancer